Cargando…
Incidence, risk factors and outcomes of checkpoint inhibitor-induced liver injury: A 10-year real-world retrospective cohort study
BACKGROUND & AIMS: Checkpoint inhibitors (CPI) account for increasing numbers of drug-induced liver injury (DILI) cases. We aimed to determine the incidence rate and risk factors associated with checkpoint inhibitor-induced liver injury (ChILI). METHODS: Prescription event monitoring was perform...
Autores principales: | Atallah, Edmond, Welsh, Sarah J., O’Carrigan, Brent, Oshaughnessy, Ana, Dolapo, Igboin, Kerr, Andrew S., Kucharczak, Joanna, Lee, Colin Y.C., Crooks, Colin, Hicks, Amy, Chimakurthi, Chenchu Ramu, Rao, Ankit, Franks, Hester, Patel, Poulam M., Aithal, Guruprasad P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505983/ https://www.ncbi.nlm.nih.gov/pubmed/37727807 http://dx.doi.org/10.1016/j.jhepr.2023.100851 |
Ejemplares similares
-
Zanubrutinib-induced liver injury: a case report and literature review
por: Atallah, Edmond, et al.
Publicado: (2021) -
Prognostic non-invasive biomarkers for all-cause mortality in non-alcoholic fatty liver disease: A systematic review and meta-analysis
por: Cianci, Nicole, et al.
Publicado: (2022) -
Fresh versus frozen PMBC using the SARS CoV-2 T-SPOT.COVID test. Which works best?
por: Nadat, Fatima, et al.
Publicado: (2022) -
Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review
por: Niu, Hao, et al.
Publicado: (2022) -
Novel function for the p38-MK2 signaling pathway in circulating CD1c+ (BDCA-1+) myeloid dendritic cells from healthy donors and advanced cancer patients; inhibition of p38 enhances IL-12 whilst suppressing IL-10
por: Franks, Hester A, et al.
Publicado: (2014)